Loan Capital Changement Date
AbbVie USD 55.63B 181M 2023-09
Abbott USD 14.56B 53M 2023-06
Amgen USD 63.17B 4.13B 2023-12
AstraZeneca USD 22.97B 2.08B 2023-09
Baxter International USD 11.13B 2.94B 2023-12
Bayer EUR 35.11B 1.45B 2023-09
Becton, Dickinson and Co. USD 14.09B 644M 2023-12
Biogen USD 6.79B 1.8M 2023-12
Boston Scientific USD 8.39B 108M 2023-09
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
CONMED USD 942.17M 29.31M 2023-09
Cooper Companies USD 2.52B 9.1M 2023-09
Dexcom USD 2.49B 2.5M 2023-12
Edwards Lifesciences USD 597M 200K 2023-12
Eli Lilly USD 17.92B 956.9M 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
GlaxoSmithKline GBP 15.99B 440M 2023-09
Globus Medical USD 417.74M 7.34M 2023-12
Hologic USD 2.54B 9.1M 2023-12
Insulet USD 1.37B 4.2M 2023-12
Integra LifeSciences USD 1.49B 65.4M 2023-12
Intuitive Surgical USD 0 0 2022-03
J&J USD 26.05B 7.85B 2023-09
Merck USD 33.97B 100M 2023-09
Merit Medical Systems USD 282.37M 52.86M 2023-09
Pfizer USD 61.05B 308M 2023-09
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 20.35B 1.05B 2023-06
Stryker USD 10.9B 519M 2023-12
Tandem Diabetes Care USD 285.03M 455K 2023-12
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09
Zimmer Biomet Holdings USD 4.87B 259.5M 2023-12
Zoetis USD 6.56B 12M 2023-12



J&J Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.